PostureCheck: A Vision-based Compensatory-posture-detection Tool for Robot-assisted Upper-limb Therapy
1 other identifier
interventional
42
1 country
1
Brief Summary
The overall objective of this study is to assess whether robot-assisted upper-limb group rehabilitation can be effectively delivered by using a camera-based system equipped with machine learning algorithms to track the quality of the exercise performance and provide feedback accordingly. To address this question, we plan to carry out a randomized clinical trial to compare outcomes in subjects receiving robot-assisted upper-limb rehabilitation during individual (i.e., one-on-one) sessions and in subjects receiving robot-assisted upper-limb rehabilitation during group (i.e., up to three subjects) sessions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable stroke
Started Apr 2024
Typical duration for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 14, 2021
CompletedFirst Posted
Study publicly available on registry
April 21, 2021
CompletedStudy Start
First participant enrolled
April 26, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
April 2, 2026
March 1, 2026
2.4 years
April 14, 2021
March 29, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change from baseline Fugl-Meyer Assessment - Upper Extremity (FMA-UE) at 7-8 weeks
Standard assessment of the severity of upper-limb motor impairments
Data will be collected at baseline and at 7-8 weeks
Secondary Outcomes (2)
Change from baseline Wolf Motor Function Test (WMFT) at 7-8 weeks
Data will be collected at baseline and at 7-8 weeks
Change from baseline Motor Activity Log (MAL) at 7-8 weeks
Data will be collected at baseline and at 7-8 weeks
Study Arms (2)
Individual robot-assisted upper-limb rehabilitation
ACTIVE COMPARATORParticipants randomized to this arm of the study will undergo 18 sessions of robot-assisted upper-limb rehabilitation. During the sessions, a therapist will administer one-on-one therapy (i.e. each study volunteer will work with a single therapist).
Group robot-assisted upper-limb rehabilitation
EXPERIMENTALParticipants randomized to this arm of the study will also undergo 18 sessions of robot-assisted upper-limb rehabilitation. However, a therapist will administer the intervention as group therapy with up to three subjects participating in the session at the same time. To facilitate the deliver of the therapeutic intervention, the robot will be equipped with a camera system (called PostureCheck) designed to track the quality of the exercises.
Interventions
Robot-assisted upper-limb individual (i.e. one-on-one) rehabilitation will be delivered using the BURT system by Barrett Technology
Robot-assisted upper-limb group (i.e. up to three subjects) rehabilitation will be delivered using the BURT system by Barrett Technology + PostureChek (a camera-based system to track the quality of the exercises)
Eligibility Criteria
You may qualify if:
- Have had a history of ischemic cerebrovascular accident (CVA) within middle cerebral artery (MCA) or anterior cerebral artery (ACA) territory
- CVA occurred between six months and six years ago
- Moderate to severe UE impairment, FMA-UE score between 15 and 45
- Mini-Mental State Examination (MMSE) score \>23 and being able to safely follow three-step commands
You may not qualify if:
- Advanced musculoskeletal pathology or recent fractures in the impaired UE
- Previous diagnosis of neurological diseases other than stroke
- Severe limitation of passive range of motion or spasticity (Modified Ashworth Scale for spasticity at \<3 for UE muscles)
- Hemorrhagic CVA or involvement of the posterior cerebral artery
- Aphasia sufficient to limit ability to express needs or discomfort verbally or non-verbally
- Impaired visual acuity (Severe visual impairments as assessed by the NIH Stroke Scale Visual Field subscale. (score \>0))
- Severe hemispatial neglect as assessed by the Line Bisection Test (score \>2)
- Severely impaired trunk control (\<4)
- Individuals who present with the following on the intended limb:
- Open wounds
- Fragile skin
- Under contact precautions due to an active infection
- Participation in another therapy focused on recovery of the impaired arm
- Subjects with cardiac pacemakers, electronic pumps or any other implanted medical devices, that are not US-certified
- Any Condition that would prevent safe use of the Burt system; such as proprioceptive deficits that impair the ability to process haptic or visual feedback, or unstable shoulder joint as assessed by physical examination
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Spaulding Rehabilitation Hospitallead
- Barrett Technologycollaborator
Study Sites (1)
Spaulding Rehabilitation Hospital
Charlestown, Massachusetts, 02129, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paolo Bonato, PhD
Harvard Medical School (HMS and HSDM)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Motion Analysis Laboratory
Study Record Dates
First Submitted
April 14, 2021
First Posted
April 21, 2021
Study Start
April 26, 2024
Primary Completion (Estimated)
September 30, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
April 2, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share